U.S. federal trademark · Serial No. 88764237 · Reg. No. 6555931
Consulting services for others, namely, designing, planning and implementing preclinical phase II trials in mice for patients suffering from cancer by utlizing patient-derived xenograft mouse models to test the efficacy of cancer drugs in treating cancer patients
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.